We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant
REVBW

20 hedge funds and large institutions have $2.4M invested in Revelation Biosciences Warrant in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

11% more funds holding

Funds holding: 18 → 20 (+2)

34% less capital invested

Capital invested by funds: $3.63M → $2.4M (-$1.23M)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
4
Closed
6
Calls
$510K
Puts
–
Net Calls
+$510K
Net Calls Change
+$510K

Top Buyers

Rank Fund Capital Flow
1
OCAM
Owl Creek Asset Management
New York
+$420K
2
HF
HRT Financial
New York
+$22.8K
3
EPM
Equitec Proprietary Markets
Illinois
+$18.4K
4
Ameriprise
Ameriprise
Minnesota
+$14K
5
UBS Group
UBS Group
Switzerland
+$4.19K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$1.33M
2
GCL
Glazer Capital LLC
New York
-$344K
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$275K
4
BFM
Boothbay Fund Management
New York
-$163K
5
Walleye Capital
Walleye Capital
New York
-$55.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
OCAM
1
Owl Creek Asset Management
New York
$670K +$420K +685,565 +229%
LA
2
Linden Advisors
New York
$452K – – –
CH
3
CVI Holdings
Delaware
$200K -$3.37K -5,500 -2%
YCM
4
Yakira Capital Management
Connecticut
$181K – – –
ICM
5
Ionic Capital Management
New York
$170K – – –
RCM
6
Rivernorth Capital Management
Florida
$136K – – –
EAM
7
Empery Asset Management
New York
$135K +$153K +250,000 New
PAMP
8
Polar Asset Management Partners
Ontario, Canada
$67K -$275K -449,214 -82%
Capstone Investment Advisors
9
Capstone Investment Advisors
New York
$62K – – –
TI
10
Telemetry Investments
New York
$55K – – –
AC
11
Ayrton Capital
Connecticut
$51K +$46K +75,000 New
EPM
12
Equitec Proprietary Markets
Illinois
$48K +$18.4K +30,000 +75%
Jane Street
13
Jane Street
New York
$37K -$132 -215 -0.4%
ICMH
14
Integrity Capital Management (HK)
Hong Kong
$34K +$30.6K +50,000 New
PFM
15
Privium Fund Management
Netherlands
$29K +$27K +44,000 New
HF
16
HRT Financial
New York
$25K +$22.8K +37,160 New
Ameriprise
17
Ameriprise
Minnesota
$16K +$14K +22,886 New
Walleye Capital
18
Walleye Capital
New York
$12K -$55.7K -90,837 -84%
SM
19
Skaana Management
New York
$12K +$10.9K +17,815 New
UBS Group
20
UBS Group
Switzerland
$5K +$4.19K +6,840 New
GCL
21
Glazer Capital LLC
New York
– -$344K -554,552 Closed
MP
22
Mangrove Partners
Connecticut
– -$1.33M -131,980 Closed
Walleye Trading
23
Walleye Trading
New York
– -$37K -60,224 Closed
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
– -$12K -19,236 Closed
PCM
25
Prelude Capital Management
New York
– -$11K -17,755 Closed
1
2

REVBW Hedge Fund Activity: Q4 2021 in Review

20 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2021, worth a combined $2.4M — down 34% from $3.63M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new REVBW positions and 6 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Owl Creek Asset Management, adding an estimated $420K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.33M sold.

  • 20 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2021, up from 18 in Q3 2021.
  • Funds reported $2.4M of Revelation Biosciences Warrant stock for Q4 2021, down 34% quarter-over-quarter.
  • 8 funds opened new Revelation Biosciences Warrant positions in Q4 2021 and 6 closed out, a net change of +2 holders.
  • The largest Revelation Biosciences Warrant buyer in Q4 2021 was Owl Creek Asset Management, an estimated $420K added.
  • The largest Revelation Biosciences Warrant seller in Q4 2021 was Mangrove Partners, an estimated $1.33M sold.

Based on aggregated 13F filings for Q4 2021.